Interacting Drugs |
Aliskiren and valsartan vs Tocilizumab |
Security Level |
 |
Mechanism |
Tocilizumab: May decrease the serum concentration of CYP3A4 Substrates. |
Management |
Monitor therapy |
Aliskiren and valsartan vs Tocilizumab
Post Review about Aliskiren and valsartan vs Tocilizumab Click here to cancel reply.
Other Interactions of Aliskiren and valsartan
Other Interactions of Tocilizumab
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.